Endress+Hauser invests in US biotech company ENDRESS HAUSER
Endress+Hauser intends to strengthen its position in the area of biotechnology through this cooperation. "Biotechnological procedures will play an increasingly important role in the future, not only in the life sciences industry but also in other industries such as the chemical industry to manufacture products in a more environmentally friendly and economical fashion," emphasizes Klaus Endress, CEO of the Endress+Hauser Group. "Our partnership with Finesse offers us the possibility of gaining experience in this area without neglecting our core business."
10 November 2011









































